Nu-Med Plus (NUMD) EPS (Basic) Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) EPS (Basic) Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.15% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 62.64% |
| Mar 31, 2025 | 40.85% |
| Dec 31, 2024 | 51.43% |
| Sep 30, 2024 | 41.23% |
| Jun 30, 2024 | 47.78% |
| Mar 31, 2024 | 52.07% |
| Dec 31, 2023 | 39.38% |
| Sep 30, 2023 | 56.70% |
| Jun 30, 2023 | 41.42% |
| Mar 31, 2023 | 37.59% |
| Dec 31, 2022 | 16.62% |
| Sep 30, 2022 | 27.16% |
| Jun 30, 2022 | 25.13% |
| Mar 31, 2022 | 15.72% |
| Dec 31, 2021 | -29.73% |
| Sep 30, 2021 | 39.33% |
| Jun 30, 2021 | 8.33% |
| Mar 31, 2021 | -22.42% |